ATE81983T1 - Absorptionsverbesserer fuer proteine. - Google Patents

Absorptionsverbesserer fuer proteine.

Info

Publication number
ATE81983T1
ATE81983T1 AT85904049T AT85904049T ATE81983T1 AT E81983 T1 ATE81983 T1 AT E81983T1 AT 85904049 T AT85904049 T AT 85904049T AT 85904049 T AT85904049 T AT 85904049T AT E81983 T1 ATE81983 T1 AT E81983T1
Authority
AT
Austria
Prior art keywords
proteins
absorption enhancers
absorption
preferably hydroxylamine
administering
Prior art date
Application number
AT85904049T
Other languages
English (en)
Inventor
Stanley Jay Sarnoff
Burton E Sobel
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/638,695 external-priority patent/US4658830A/en
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Application filed by Survival Technology filed Critical Survival Technology
Application granted granted Critical
Publication of ATE81983T1 publication Critical patent/ATE81983T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/19Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT85904049T 1984-08-08 1985-08-08 Absorptionsverbesserer fuer proteine. ATE81983T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US06/638,695 US4658830A (en) 1984-08-08 1984-08-08 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A 1985-03-27 1985-03-27
EP85904049A EP0191814B1 (de) 1984-08-08 1985-08-08 Absorptionsverbesserer für proteine
PCT/US1985/001504 WO1986001109A1 (en) 1984-08-08 1985-08-08 Protein absorption enhancing agents

Publications (1)

Publication Number Publication Date
ATE81983T1 true ATE81983T1 (de) 1992-11-15

Family

ID=27417624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85904049T ATE81983T1 (de) 1984-08-08 1985-08-08 Absorptionsverbesserer fuer proteine.

Country Status (7)

Country Link
EP (1) EP0191814B1 (de)
AT (1) ATE81983T1 (de)
AU (1) AU591069B2 (de)
CA (1) CA1264030A (de)
DE (1) DE3586795T2 (de)
IL (1) IL76121A0 (de)
WO (1) WO1986001109A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US4305947A (en) * 1980-08-26 1981-12-15 Survival Technology, Inc. Stable aqueous solutions of pralidoxime salts
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
EP0201153A3 (de) * 1985-02-09 1987-10-07 Beecham Group Plc Modifiziertes Enzym und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
AU591069B2 (en) 1989-11-30
CA1264030A (en) 1989-12-27
DE3586795T2 (de) 1993-05-19
AU4721185A (en) 1986-03-07
EP0191814B1 (de) 1992-11-04
EP0191814A1 (de) 1986-08-27
IL76121A0 (en) 1985-12-31
WO1986001109A1 (en) 1986-02-27
DE3586795D1 (de) 1992-12-10
EP0191814A4 (de) 1987-03-16

Similar Documents

Publication Publication Date Title
ATE113213T1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
SE8800731D0 (sv) Phenyl carbamate
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
EP0191056A4 (de) T-pa zusammensetzung und verfahren zu deren aufnahme in den blutstrom.
ATE113960T1 (de) Proteingewinnung.
DK261490D0 (da) New pharmaceutical compound
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ATE81983T1 (de) Absorptionsverbesserer fuer proteine.
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
DK528386A (da) Proteinabsorptionsforoegende midler
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
DE3873825T2 (de) Die proteinabsorption verbessernde stoffe.
DK623984A (da) Farmaceutisk doseringsenhed
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
KR870700020A (ko) 단백질 흡수증가제
IT8804860A0 (it) Procedimento per il recupero di calore, con eventuale recupero od uso dell'umidita', ceduto direttamente o indirettamente dal corpo umano e dispositivo per la sua attuazione.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
SU681928A1 (ru) Адъювант

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties